Klebsiella pneumoniae: biology, ecology, and clinical significance

History and discovery

Associations between a characteristic severe lobar pneumonia and a mucoid organism were reported in the 19th century; early observers linked the agent to disease of the lungs. Subsequent bacteriologic work established the species now called Klebsiella pneumoniae and clarified its role as both an environmental organism and an opportunistic human pathogen.

Taxonomy, structure and laboratory identification

The species is part of a group of closely related organisms and is divided into multiple lineages and strains that differ in capsule type and virulence. In the laboratory it is commonly identified by growth characteristics such as lactose fermentation on selective media, production of mucoid colonies due to capsule, and standard biochemical or molecular tests. Hypervirulent variants may display a positive "string test" reflecting a hypermucoviscous phenotype. Clinical laboratories perform culture and antimicrobial susceptibility testing to guide therapy.

Ecology and reservoirs

Klebsiella species are widespread in nature. They are frequently isolated from the human intestinal tract and may also be found on the mouth and skin as part of the normal flora. Environmental reservoirs include soil, fresh water and decaying plant material. Some environmental isolates have metabolic traits such as the ability to fix nitrogen under oxygen-limited conditions; these capabilities link them ecologically to nutrient cycling and the processing of atmospheric nitrogen via biological nitrogen fixation.

Clinical infections and presentation

When it spreads beyond its usual sites, K. pneumoniae can cause a variety of infections: community-acquired and hospital-associated pneumonia, urinary tract infections, bloodstream infections (sepsis), intra-abdominal infections and meningitis. In severe lung infections it has been classically associated with production of thick, mucoid, often blood-tinged or "currant jelly" sputum.

Transmission and epidemiology

Transmission commonly occurs by direct contact, especially in healthcare settings where contaminated hands, instruments, or surfaces can spread the organism. Outbreaks are frequently linked to lapses in infection control. Although the bacterium can contaminate the environment, airborne spread is not the usual route for transmission of typical strains.

Pathogenesis and virulence factors

Major virulence determinants include the polysaccharide capsule, which protects against phagocytosis, and various surface structures and secreted factors that facilitate adherence, iron acquisition and immune evasion. Hypervirulent strains may carry additional plasmid-borne genes that increase invasiveness and produce a hypermucoviscous appearance.

Diagnosis, treatment and antimicrobial resistance

Diagnosis is based on clinical presentation and recovery of the organism from appropriate specimens (sputum, urine, blood, wound swabs) with confirmation and susceptibility testing by the clinical laboratory. Management depends on infection site and susceptibility results. A major public-health problem is the global emergence of strains producing extended-spectrum beta-lactamases (ESBLs) and carbapenemases (for example, KPC, NDM and related enzymes) that render multiple antibiotic classes ineffective. These resistance mechanisms have led to increased use of specialized diagnostics, combination therapies and emphasis on antimicrobial stewardship.

Prevention and control

Prevention relies on standard infection-control measures: strict hand hygiene, appropriate use of personal protective equipment and environmental cleaning in healthcare settings, isolation or cohorting of colonized or infected patients when indicated, surveillance for resistant strains, and prudent antibiotic prescribing. Public-health responses to outbreaks include enhanced screening, molecular typing of isolates and reinforcement of control practices.

Research and public health importance

Current research areas include vaccine development, novel antimicrobials and alternative strategies such as bacteriophage therapy, and improved rapid diagnostics to detect resistance. Understanding the ecology and genetic diversity of environmental and clinical strains helps public-health authorities assess risk and design interventions. For clinical context and basic taxonomy see entries on the genus Klebsiella and broader discussions of microbial ecology in natural environments.

Selected related links: bacterium, soil, water, nitrogen fixation, atmosphere.